{"summary": "all children 5 years of age admitted to the pediatric wards of King Hussein Medical Centre (KHMC) and Queen Alia Hospital (QAH) were enrolled in the study after informed consent was obtained from parents or guardians. the study determined the etiology, inflammatory responses, and clinical effects of ARI. HBoV was detected in 30 (21.7%) of 138 children with severe ARI and in 27 (15.5%) of 174 children with mild-to-moderate ARI. only HBoV was detected in 13 (48%) of the 27 patients with mild-to-moderate ARI and with adenovirus (10 patients), RSV (2 patients) and adenovirus (1 patient) in the 14 remaining patients with mild-to-moderate disease. median age was 3.5 months for those infected only with HBoV. 10 months (p = 0.012) for those co-infected with HBoV and other potential pathogens. no connections were found between patients with different variants except for AB243570. HBoV was detected in 57 (18.3%) of 312 children with severe ARI. other reported prevalences are 24 (3%) of 806 pediatric samples in Sweden (8), 18 (5.6%) of 324 children 3 years of age in Australia (6), and 18 (5.7%) of 318 children 3 years of age in Japan (13). CPV-1 strains showed 96.5%, 92.5%, and 97.5% homology in their NS-1-, NP-1-, and VP1/2-deduced proteins (15)."}